Work

Letter to the Editor: Mesenchymal stromal cell-derived extracellular vesicles as a promising therapeutic candidate for attenuating cellular senescence

Year: 2026
Type: letter
Abstract: Cellular senescence, characterized by an irreversible growth arrest, plays a pivotal role in aging and age-related pathologies. The study by Yang et al investigated the therapeutic potential of mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) in mitigating cellular senescence, providing comprehensive evidence from both in vitro and in vivo experiments. A clinical-grade production process for MSC-EVs was established, along with defined release criteria for human application. Functional assays revealed that MSC-EVs significantly reduced senescence-associated markers, including β-galactosidase, matrix metallopeptidase 1, P21, and interleukin-1β, while enhancing collagen I expression in aged human dermal fibroblasts. In a D-gal-induced aging mouse model, MSC-EVs ameliorated histopathological alterations, oxidative stress, and aging-related gene expression. Collectively, these findings underscore MSC-EVs as a promising anti-aging therapeutic strategy. Future research should focus on identifying the critical quality attributes of anti-senescent MSC-EVs and validating their efficacy in large animal models and clinical trials.
Language: English
Open Access status: hybrid
OpenAlex ID: W7140216351
Cites: 10
Cited by:
Related to: 9